UY28148A1 - Bromhidrato de escitalopram y un metodo para su preparacion - Google Patents

Bromhidrato de escitalopram y un metodo para su preparacion

Info

Publication number
UY28148A1
UY28148A1 UY28148A UY28148A UY28148A1 UY 28148 A1 UY28148 A1 UY 28148A1 UY 28148 A UY28148 A UY 28148A UY 28148 A UY28148 A UY 28148A UY 28148 A1 UY28148 A1 UY 28148A1
Authority
UY
Uruguay
Prior art keywords
preparation
scitalopram
bromhydrate
escitalopram
citalopram
Prior art date
Application number
UY28148A
Other languages
English (en)
Spanish (es)
Inventor
Hans Petersen
Robert Dancer
Peter Ellegaard
Lawrence Martel
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32668635&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=UY28148(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of UY28148A1 publication Critical patent/UY28148A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Addiction (AREA)
  • Child & Adolescent Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Psychology (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Nutrition Science (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
UY28148A 2002-12-23 2003-12-23 Bromhidrato de escitalopram y un metodo para su preparacion UY28148A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DKPA200202005 2002-12-23

Publications (1)

Publication Number Publication Date
UY28148A1 true UY28148A1 (es) 2004-09-30

Family

ID=32668635

Family Applications (1)

Application Number Title Priority Date Filing Date
UY28148A UY28148A1 (es) 2002-12-23 2003-12-23 Bromhidrato de escitalopram y un metodo para su preparacion

Country Status (32)

Country Link
US (1) US20040167209A1 (cg-RX-API-DMAC7.html)
EP (1) EP1578738B1 (cg-RX-API-DMAC7.html)
JP (2) JP4658613B2 (cg-RX-API-DMAC7.html)
KR (1) KR20050086933A (cg-RX-API-DMAC7.html)
CN (1) CN100349885C (cg-RX-API-DMAC7.html)
AR (1) AR042652A1 (cg-RX-API-DMAC7.html)
AT (1) ATE388947T1 (cg-RX-API-DMAC7.html)
AU (1) AU2003287919B2 (cg-RX-API-DMAC7.html)
BR (1) BR0317623A (cg-RX-API-DMAC7.html)
CA (1) CA2511142A1 (cg-RX-API-DMAC7.html)
CY (1) CY1107451T1 (cg-RX-API-DMAC7.html)
DE (1) DE60319739T2 (cg-RX-API-DMAC7.html)
DK (1) DK1578738T3 (cg-RX-API-DMAC7.html)
EA (1) EA013116B1 (cg-RX-API-DMAC7.html)
EG (1) EG24729A (cg-RX-API-DMAC7.html)
ES (1) ES2298595T3 (cg-RX-API-DMAC7.html)
IL (1) IL169125A0 (cg-RX-API-DMAC7.html)
IS (1) IS2654B (cg-RX-API-DMAC7.html)
ME (1) MEP5808A (cg-RX-API-DMAC7.html)
MX (1) MXPA05005772A (cg-RX-API-DMAC7.html)
MY (1) MY135468A (cg-RX-API-DMAC7.html)
NO (1) NO20053595L (cg-RX-API-DMAC7.html)
NZ (1) NZ540281A (cg-RX-API-DMAC7.html)
PE (1) PE20040924A1 (cg-RX-API-DMAC7.html)
PL (1) PL378275A1 (cg-RX-API-DMAC7.html)
PT (1) PT1578738E (cg-RX-API-DMAC7.html)
RS (1) RS51092B (cg-RX-API-DMAC7.html)
TW (1) TW200501943A (cg-RX-API-DMAC7.html)
UA (1) UA80170C2 (cg-RX-API-DMAC7.html)
UY (1) UY28148A1 (cg-RX-API-DMAC7.html)
WO (1) WO2004056791A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA200504109B (cg-RX-API-DMAC7.html)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050137255A1 (en) * 2002-12-23 2005-06-23 H. Lundbeck A/S Crystalline escitalopram hydrobromide and methods for preparing the same
NZ540281A (en) * 2002-12-23 2008-07-31 Lundbeck & Co As H Escitalopram hydrobromide and a method for the preparation thereof
NZ549100A (en) * 2004-03-05 2010-02-26 Lundbeck & Co As H Crystalline composition containing escitalopram oxalate
US7834201B2 (en) 2005-06-22 2010-11-16 H. Lundbeck A/S Crystalline base of escitalopram and orodispersible tablets comprising escitalopram base
TWI358407B (en) * 2005-06-22 2012-02-21 Lundbeck & Co As H Crystalline base of escitalopram and orodispersibl
KR20080080094A (ko) * 2005-10-14 2008-09-02 하. 룬트벡 아크티에 셀스카브 에스시탈로프람 및 부프로피온의 저용량 조합물을 이용한중추신경계 장애의 치료 방법
AU2006304889A1 (en) * 2005-10-14 2007-04-26 H. Lundbeck A/S Stable pharmaceutical formulations containing escitalopram and bupropion
TW200812993A (en) * 2006-05-02 2008-03-16 Lundbeck & Co As H New uses of escitalopram
EP2042499B1 (en) * 2006-07-11 2018-06-27 Mitsubishi Tanabe Pharma Corporation Salt of a morpholine compound
WO2008059514A2 (en) * 2006-07-31 2008-05-22 Cadila Healthcare Limited Process for preparing escitalopram
FR3006594A1 (fr) * 2013-06-11 2014-12-12 Sorin Crm Sas Microsonde implantable de detection/stimulation incorporant un agent anti-inflammatoire
CN108976188B (zh) * 2017-06-05 2022-12-06 上海奥博生物医药股份有限公司 一种艾司西酞普兰双羟萘酸盐新的制备方法
AU2018349284B2 (en) * 2017-10-09 2023-11-16 428 Pharma BV. New salt and solid state forms of escitalopram
US20240100012A1 (en) 2021-01-18 2024-03-28 Mark Hasleton Pharmaceutical dosage form

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US34712A (en) * 1862-03-18 James h
GB1526331A (en) * 1976-01-14 1978-09-27 Kefalas As Phthalanes
GB8419963D0 (en) * 1984-08-06 1984-09-12 Lundbeck & Co As H Intermediate compound and method
GB8814057D0 (en) * 1988-06-14 1988-07-20 Lundbeck & Co As H New enantiomers & their isolation
WO2000023431A1 (en) * 1998-10-20 2000-04-27 H. Lundbeck A/S Method for the preparation of citalopram
AR021155A1 (es) * 1999-07-08 2002-06-12 Lundbeck & Co As H Tratamiento de desordenes neuroticos
HK1043129B (zh) * 1999-10-25 2004-10-21 H‧隆德贝克有限公司 西酞普蘭的製備方法
JP2002020379A (ja) * 2000-05-02 2002-01-23 Sumika Fine Chemicals Co Ltd シタロプラム臭化水素酸塩の結晶およびその結晶化方法
US6977306B2 (en) * 2000-05-02 2005-12-20 Sumitomo Chemical Company, Limited Citalopram hydrobromide crystal and method for crystallization thereof
CA2353693C (en) * 2000-08-10 2003-07-22 H. Lundbeck A/S Pharmaceutical composition containing citalopram
ES2223959T3 (es) * 2000-12-04 2005-03-01 Westfalia Separator Ag Procedimiento de pretratamiento de aceites en bruto y grasas en bruto para la produccion de esteres de acidos grasos.
CA2445843A1 (en) * 2001-05-01 2002-11-07 H. Lundbeck A/S The use of enantiomeric pure escitalopram
AR034612A1 (es) * 2001-06-25 2004-03-03 Lundbeck & Co As H Proceso para la preparacion del citalopram racemico y/o del s- o r-citalopram mediante la separacion de una mezcla de r- y s-citalopram
NZ540281A (en) * 2002-12-23 2008-07-31 Lundbeck & Co As H Escitalopram hydrobromide and a method for the preparation thereof
US20050174782A1 (en) * 2003-03-25 2005-08-11 Chapman Leonard T. Flashlight

Also Published As

Publication number Publication date
NZ540281A (en) 2008-07-31
MXPA05005772A (es) 2005-08-16
ES2298595T3 (es) 2008-05-16
EP1578738B1 (en) 2008-03-12
EG24729A (en) 2010-06-21
CA2511142A1 (en) 2004-07-08
EA013116B1 (ru) 2010-02-26
IL169125A0 (en) 2009-02-11
BR0317623A (pt) 2005-11-29
US20040167209A1 (en) 2004-08-26
MEP5808A (xx) 2010-02-10
DE60319739D1 (de) 2008-04-24
JP2006514952A (ja) 2006-05-18
ZA200504109B (en) 2006-08-30
MY135468A (en) 2008-04-30
AR042652A1 (es) 2005-06-29
KR20050086933A (ko) 2005-08-30
AU2003287919A1 (en) 2004-07-14
JP2011037893A (ja) 2011-02-24
UA80170C2 (en) 2007-08-27
ATE388947T1 (de) 2008-03-15
CY1107451T1 (el) 2012-12-19
RS51092B (sr) 2010-10-31
IS2654B (is) 2010-08-15
JP4658613B2 (ja) 2011-03-23
IS7848A (is) 2005-05-17
PL378275A1 (pl) 2006-03-20
AU2003287919B2 (en) 2009-11-12
DK1578738T3 (da) 2008-06-30
HK1087708A1 (en) 2006-10-20
RS20050487A (sr) 2007-06-04
CN1726202A (zh) 2006-01-25
PE20040924A1 (es) 2004-12-11
EP1578738A1 (en) 2005-09-28
NO20053595L (no) 2005-09-05
PT1578738E (pt) 2008-04-11
EA200501046A1 (ru) 2005-12-29
TW200501943A (en) 2005-01-16
WO2004056791A1 (en) 2004-07-08
DE60319739T2 (de) 2008-07-17
CN100349885C (zh) 2007-11-21

Similar Documents

Publication Publication Date Title
ATE289640T1 (de) Amidofunktionelle aminopolydiorganosiloxane
CY1107451T1 (el) Υδροβρωμικον escitalopram και μεθοδος δια την παρασκευη αυτου
BR0106100B1 (pt) composição de gesso fixado, artigo, e, método para preparar uma composição de gesso fixado.
EA200100022A1 (ru) Композиции с контролируемым высвобождением пароксетина
DE602004021120D1 (de) Photopolymerisierbare zusammensetzung.
IT1317757B1 (it) Metodo per la preparazione di idrocarburi idrogenati.
MXPA03001329A (es) Metodo para la preparacion de citalopram.
CR7583A (es) Nueva sal formiato de o-desmetil venlafaxina
BR0114221B1 (pt) composição de gesso, processo para fabricação de uma composição de gesso, chapa de gesso e processo para fabricação de chapa de gesso.
MXPA03005222A (es) Derivado de metanosulfonamido-benzofurano, su procedimiento de preparacion y su utilizacion como intermediario de sisntesis.
DK1682530T3 (da) Pyrrolsubstituerede indoler som inhibitorer af PAI-1
HRP20070374T3 (en) Formulations comprising ecteinascidin and a disaccharide
BR9902726B1 (pt) composições estocáveis para cimentação de poços de óleo e gás.
NO20070391L (no) Jernsulfatbasert fosfatadsorbent
BR0204916B1 (pt) mÉtodo para produzir uma olefina.
CO5601045A2 (es) Procedimiento para la fabricacion de compuestos organicos
ECSP034531A (es) Derivados sustituidos de c-ciclohexilmetilamina
NO20051187L (no) Depotformuleringer bestaende av aktive arylheterocykliske forbindelser i form av en suspensjon
PT1246813E (pt) Metodo para a preparacao de citalopram
UY26954A1 (es) Procedimiento para preparar 3-amino-2-cloro-4-metilpiridina
BR0101437A (pt) Método para preparar um ciclopropeno
IT1318436B1 (it) Ciclopentadieni sostituiti policiclici e metodo per la loropreparazione.
NL1017717A1 (nl) Gecombineerde plantencoagulaatsamenstelling, werkwijze voor de bereiding ervan en toepassing ervan.
DK1503803T3 (da) Injicerbar farmaceutisk sammensætning indeholdende ethanol til at behandle diskusprolaps
PT1408035E (pt) Metodo de preparacao de derivativos de 1.5-diaril-3-trifluorometilo-delta2-pirazolinas que sejam racemicos e enanciomericamente puros

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20150513